Summary
- Current Price
- As of today, SNY price is $46.90, up +1.65% in the most recent trading session on
- Current Price All-Time High
- SNY price is currently -21.99% below its historical high of $60.12 set on
- Market Cap
- SNY current market cap is $114B, down -13.19% year-over-year
- PE Ratio
- SNY current PE ratio is 22.28
- Revenue
- SNY current annual revenue is $49.24B, up +10.80% year-over-year
- Next Earnings
- The next earnings release for SNY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Sanofi |
| Ticker | NASDAQ: SNY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | France |
| IPO | |
| Indexes | Not included |
| Website | sanofi.com |
| Employees | 82,878 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $46.90 | |
| Price, 1D Change | +1.65% | |
| Market Cap | $114B | |
| TTM Dividend Yield | 4.68% | |
| PE Ratio | 22.28 | |
| Beta | 0.35 | |
| Revenue | $49B | |
| Revenue, 1Y Change | +10.80% | |
| EPS | $0.00 | |
| EPS, 1Y Change | -100.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.20 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.00 | |
| EPS Estimate | N/A | $5.00 |
| EPS Est. Change | N/A | - |
| Revenue | $49.24B | |
| Revenue Estimate | N/A | $46.38B |
| Revenue Est. Change | N/A | -5.79% |
| Current Price | $46.90 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.97 | $2.39 | -39.75% | |
| $4.60 | $0.00 | -100.00% | |
| $5.00 | N/A | - | |
| $5.30 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $43.77B | $44.44B | +1.53% | |
| $43.51B | $49.24B | +13.15% | |
| $46.38B | N/A | -5.79% | |
| $49.32B | N/A | +0.17% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -12.50% | |
| Price, 3Y | -1.62% | |
| Market Cap, 1Y | -13.19% | |
| Market Cap, 3Y | -4.31% | |
| Revenue, 1Y | +10.80% | |
| Revenue, 3Y | +8.95% | |
| EPS, 1Y | -100.00% | |
| EPS, 3Y | -100.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $46.90 | |
| SMA 200 | $48.98 | |
| SMA 200 vs Price | +4.43% | |
| SMA 50 | $47.71 | |
| SMA 50 vs Price | +1.73% | |
| Beta | 0.35 | |
| ATR | $0.97 | |
| 14-Day RSI | 42.21 | |
| 10-Day Volatility | 29.99% | |
| 1-Year Volatility | 27.77% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $2.20 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 4.68% | |
| Total Dividend | $2.20 | |
| Dividends Paid | - | |
| Payout Ratio | - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $49.24B | |
| EPS | $0.00 | |
| Gross Profit | $34.51B | |
| Gross Margin | 70.09% | |
| Operating Profit | $16.08B | |
| Operating Margin | 32.67% | |
| Net Income | $5.62B | |
| Net Margin | 11.41% | |
| EBITDA | - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.28 | |
| Current Ratio | 1.09 | |
| Quick Ratio | - | |
| Interest Coverage | - | |
| F-Score | - | |
| Altman Z-Score | - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 22.28 | |
| PS Ratio | 3.36 | |
| PB Ratio | - | |
| EV/EBITDA | - | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $84.22B | |
| Cash & Equivalents | $8.99B | |
| Total Assets | $148.93B | |
| Current Assets | $36.35B | |
| Total Liabilities | $64.71B | |
| Current Liabilities | $33.29B | |
| Total Debt | $23.88B | |
| Short Term Debt | $5.42B | |
| Accounts Payable | $26.93B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $43.66B | |
| Operating Expenses | $18.43B | |
| Cost Of Goods Sold | $14.73B | |
| SG&A | $10.77B | |
| D&A | - | |
| Interest Expense | $0.00 | |
| Income Tax | $1.18B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $12.13B | |
| CFI | -$2.76B | |
| CFF | -$9.26B | |
| Capex | - | |
| Free Cash Flow | $12.13B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| Barclays | → | |
| Guggenheim | → | |
| JP Morgan | → | |
| Morgan Stanley | → | |
| Deutsche Bank | → | |
| JP Morgan | → | |
| Goldman Sachs | ||
| Argus Research | → | |
| Morgan Stanley |
Analyst sentiment
Institutional ownership
Screeners with SNY
FAQ
What is the ticker symbol for Sanofi?
The ticker symbol for Sanofi is NASDAQ:SNY
Does Sanofi pay dividends?
Yes, Sanofi pays dividends. The last payment was $2.20, with an ex-dividend date on May 9, 2025
What sector is Sanofi in?
Sanofi is in the Healthcare sector
What industry is Sanofi in?
Sanofi is in the General Drug Manufacturers industry
What country is Sanofi based in?
Sanofi is headquartered in France
When did Sanofi go public?
Sanofi initial public offering (IPO) was on July 1, 2002
Is Sanofi in the S&P 500?
No, Sanofi is not included in the S&P 500 index
Is Sanofi in the NASDAQ 100?
No, Sanofi is not included in the NASDAQ 100 index
Is Sanofi in the Dow Jones?
No, Sanofi is not included in the Dow Jones index
When was Sanofi last earnings report?
Sanofi's most recent earnings report was on January 29, 2026
When does Sanofi report earnings?
The next expected earnings date for Sanofi is April 23, 2026
Data Sources & References
- SNY Official Website www.sanofi.com
- SNY Profile on Yahoo Finance finance.yahoo.com/quote/SNY
- SNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sny